Silexion Therapeutics (SLXN) Short Interest Ratio & Short Volume

Short interest is the volume of Silexion Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 113,300 shares of SLXN short. 6.83% of Silexion Therapeutics' shares are currently sold short. Learn More on Silexion Therapeutics' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.83% of Silexion Therapeutics' floating shares are currently sold short.

Silexion Therapeutics saw a increase in short interest in September. As of September 15th, there was short interest totaling 113,300 shares, an increase of 472.2% from the previous total of 19,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Silexion Therapeutics currently has issued a total of 732,000 shares. Some of Silexion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Silexion Therapeutics currently has a public float of 1,660,000 shares.

6.83% of Silexion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Silexion Therapeutics: Addex Therapeutics Ltd. Sponsored ADR (5.61%), Heatwurx Inc. (1.81%), AEON Biopharma, Inc. (1.15%), Avalon GloboCare Corp. (5.21%), TransCode Therapeutics Inc. (7.04%), ESSA Pharma Inc. (2.85%), Synaptogenix, Inc. (12.63%), Aprea Therapeutics, Inc. (1.68%), Creative Medical Technology Holdings, Inc. (3.97%), Ernexa Therapeutics Inc. (1.11%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling SLXN is an investing strategy that aims to generate trading profit from Silexion Therapeutics as its price is falling. SLXN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Silexion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLXN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLXN, twice per month. The most recent reporting period available is September, 15 2025.